BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31707784)

  • 1. Exploring Relationships Among Peripheral Amyloid Beta, Tau, Cytokines, Cognitive Function, and Psychosomatic Symptoms in Breast Cancer Survivors.
    Henneghan A; Haley AP; Kesler S
    Biol Res Nurs; 2020 Jan; 22(1):126-138. PubMed ID: 31707784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cross-Sectional Exploration of Cytokine-Symptom Networks in Breast Cancer Survivors Using Network Analysis.
    Henneghan A; Wright ML; Bourne G; Sales AC
    Can J Nurs Res; 2021 Sep; 53(3):303-315. PubMed ID: 32482100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition.
    Tideman P; Stomrud E; Leuzy A; Mattsson-Carlgren N; Palmqvist S; Hansson O;
    Neurology; 2022 Apr; 98(15):e1525-e1533. PubMed ID: 35022305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
    Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O
    JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
    Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
    ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.
    Startin CM; Ashton NJ; Hamburg S; Hithersay R; Wiseman FK; Mok KY; Hardy J; Lleó A; Lovestone S; Parnetti L; Zetterberg H; Hye A; ; Strydom A
    Alzheimers Res Ther; 2019 Mar; 11(1):26. PubMed ID: 30902060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.
    Soares JZ; Valeur J; Šaltytė Benth J; Knapskog AB; Selbæk G; Bogdanovic N; Pettersen R
    J Alzheimers Dis; 2022; 89(3):825-834. PubMed ID: 35938253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.
    Mielke MM; Hagen CE; Wennberg AMV; Airey DC; Savica R; Knopman DS; Machulda MM; Roberts RO; Jack CR; Petersen RC; Dage JL
    JAMA Neurol; 2017 Sep; 74(9):1073-1080. PubMed ID: 28692710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
    Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
    J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel.
    Gill J; Mustapic M; Diaz-Arrastia R; Lange R; Gulyani S; Diehl T; Motamedi V; Osier N; Stern RA; Kapogiannis D
    Brain Inj; 2018; 32(10):1277-1284. PubMed ID: 29913077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion.
    Henneghan A; Stuifbergen A; Becker H; Kesler S; King E
    J Cancer Surviv; 2018 Apr; 12(2):224-233. PubMed ID: 29116555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
    Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
    Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of sleep duration and physical activity on cognitive performance are influenced by β-amyloid and brain volume but not tau burden among cognitively unimpaired older adults.
    Aslanyan V; Ortega N; Fenton L; Harrison TM; Raman R; Mack WJ; Pa J
    Neuroimage Clin; 2023; 39():103460. PubMed ID: 37379733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans.
    Peltz CB; Kenney K; Gill J; Diaz-Arrastia R; Gardner RC; Yaffe K
    Neurology; 2020 Sep; 95(9):e1126-e1133. PubMed ID: 32571850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
    Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
    Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Aβ42 and Total Tau Predict Cognitive Decline in Amnestic Mild Cognitive Impairment.
    Chen TB; Lee YJ; Lin SY; Chen JP; Hu CJ; Wang PN; Cheng IH
    Sci Rep; 2019 Sep; 9(1):13984. PubMed ID: 31562355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition.
    Rauchmann BS; Schneider-Axmann T; Perneczky R;
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1289-1295. PubMed ID: 34187867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.